The rising demand for personalized medicine, increasing support from local governments via initiatives and public policies, and faltering costs of sequencing services are driving Asia-Pacific’s genomics market to record heights. This growth is also coupled with increasing partnerships among the key players in the market, who are aiming to expand their product portfolios, fostering their development and enhancing their global footprint. Governments in APAC are investing heavily in the implementation of several initiatives that promote the efficient development of genomics solutions. These solutions find application in a myriad of segments, such as diagnostics, precision medicine, drug development and delivery, animal research, and agriculture.
According to P&S Intelligence, the market will witness a stagging 12.7% CAGR between 2022 and 2030. In 2019 alone, APAC’s genomics market generated over 18 billion USD in revenue, which is expected to skyrocket to 68 billion by 2030. Owing to such significant growth and escalating utilization of high-throughput technologies, it is evident that APAC will continue to remain at the forefront of innovation in the global genomics firmament, enabling the life sciences community to enhance its offerings.
This edition of Life Sciences Review APAC lays the spotlight on the key developments in APAC’s genomics domain and how companies are leveraging contemporary technologies to mitigate the risks associated with mercurial market scenarios.
This edition also features thought leadership articles by Narayana Rao, Vice President of Biopharma APAC-MEA and Marianthi Psaha, Global Head of Cell and & Gene Therapy of Santen, sharing their views on how cell and gene therapy will lead the biomanufacturing industry and how leveraging contemporary technologies can improve gene therapy.
Along with that, the edition features innovative genomics solutions companies, including Genolution, OPTOLANE Technologies, and Zinexts. These companies offer groundbreaking genomics solutions, helping APAC’s life science industry navigate the myriad of challenges associated with molecular biology, clinical research, drug development, and disease diagnostics.
We present to you the “Top 10 Genomics Solution Providers in APAC - 2022.